Page 32 - P4304.1-V99_PS Magazine - July 24

Top tips from your

Dispensing Doctor

Account Manager

James Durnall, DDAM for Wales &

West Midlands

James has worked for PSUK for just over a year
but has spent the past 20 years working with
various branded pharma companies promoting
their branded products to both dispensing and
non-dispensing patients. This month, James

talks about VPAG - a scheme that impacts
branded pharma companies and its effect
on your dispensary.

Staying Profitable with VPAG:
Insights for Dispensing Doctors

I have worked for PSUK for the last year, having
worked for the previous 20 years with many
pharmaceutical companies promoting their branded
products and working with both dispensing and non-
dispensing doctors across the Midlands and Wales.
My last 20 years working in pharma have seen many
changes. Over this time, there have been numerous
changes in the pharmaceutical industry involving
companies, product portfolios, and pipelines of
medicines.
In recent years, you may have noticed that many
branded and generic products are no longer
available. This is due to various reasons such as
the cost and availability of raw ingredients, the
cost of fuel, and overall manufacturing costs.
A contributing factor in recent years for
pharmaceutical companies has been VPAS
(The Voluntary Scheme for Branded Medicines
Pricing and Access). This is an agreement

32 PS Magazine | Dispensing Doctor Account Manager’s Top tips

05/06/2024 16:26:25
P4304.1-V99_PS Magazine - July 24.indd 32 05/06/2024 16:26:25
P4304.1-V99_PS Magazine - July 24.indd 32